Literature DB >> 15961512

Platelets express functional Toll-like receptor-4.

Graciela Andonegui1, Steven M Kerfoot, Kelly McNagny, Kirsten V J Ebbert, Kamala D Patel, Paul Kubes.   

Abstract

Profound thrombocytopenia occurs in humans with sepsis and in mice administered lipopolysaccharide (LPS). Growing evidence indicates that platelets may contribute to these abnormalities, but whether that is a direct result of LPS activation of platelets or an indirect result of other inflammatory mechanisms remains unclear. Here we demonstrate that although platelets do not increase P-selectin expression in response to LPS, platelets bind more avidly to fibrinogen under flow conditions in a Toll-like receptor-4 (TLR4)-dependent manner. In addition, we find that CD41+ megakaryocytes grown from fetal livers and adult circulating platelets express significant amounts of TLR4. LPS induced thrombocytopenia in wild-type mice but not in TLR4-deficient (TLR4def) mice. Wild-type platelets accumulated in the lungs of wild-type mice in response to LPS; TLR4def platelets did not. However, wild-type platelets did not accumulate in the lungs of LPS-treated TLR4def mice. Neutrophils also accumulated in the lungs, and this preceded platelet accumulation. Neutrophil depletion completely abolished LPS-induced platelet sequestration into the lungs, but platelet depletion did not affect neutrophil accumulation. Thus, our data show for the first time that platelets do express functional levels of TLR4, which contribute to thrombocytopenia through neutrophil-dependent pulmonary sequestration in response to LPS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961512     DOI: 10.1182/blood-2005-03-0916

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  158 in total

1.  Abundance- and Activity-Based Proteomics in Platelet Biology.

Authors:  Stephen P Holly; Xian Chen; Leslie V Parise
Journal:  Curr Proteomics       Date:  2011-10       Impact factor: 0.837

Review 2.  Platelets as immune mediators: their role in host defense responses and sepsis.

Authors:  Zhenyu Li; Fanmuyi Yang; Steve Dunn; A Kendall Gross; Susan S Smyth
Journal:  Thromb Res       Date:  2010-11-13       Impact factor: 3.944

Review 3.  Platelets as central mediators of systemic inflammatory responses.

Authors:  Tammy L Smith; Andrew S Weyrich
Journal:  Thromb Res       Date:  2010-11-11       Impact factor: 3.944

4.  Roles of protease-activated receptors in a mouse model of endotoxemia.

Authors:  Eric Camerer; Ivo Cornelissen; Hiroshi Kataoka; Daniel N Duong; Yao-Wu Zheng; Shaun R Coughlin
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

Review 5.  Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes.

Authors:  Majed A Refaai; Richard P Phipps; Sherry L Spinelli; Neil Blumberg
Journal:  Thromb Res       Date:  2010-11-19       Impact factor: 3.944

6.  Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway.

Authors:  Guoying Zhang; Jingyan Han; Emily J Welch; Richard D Ye; Tatyana A Voyno-Yasenetskaya; Asrar B Malik; Xiaoping Du; Zhenyu Li
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

Review 7.  Intravascular immunity: the host-pathogen encounter in blood vessels.

Authors:  Michael J Hickey; Paul Kubes
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

Review 8.  Amicus or adversary: platelets in lung biology, acute injury, and inflammation.

Authors:  Fernando A Bozza; Amrapali M Shah; Andrew S Weyrich; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-21       Impact factor: 6.914

Review 9.  Megakaryocytes as immune cells.

Authors:  Pierre Cunin; Peter A Nigrovic
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

10.  Use of low-molecular-weight heparin to decrease mortality in mice after intracardiac injection of tumor cells.

Authors:  Kim L Stocking; Jon C Jones; Nancy E Everds; Bernard S Buetow; Martine P Roudier; Robert E Miller
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.